Table 1.
ILD | PARo52A | (CI 95%) | |||
---|---|---|---|---|---|
Ss, % | Sp, % | PPV, % | NPV, % | ||
n = 26 | n = 35 | 96.2 (89–100) | 83.3 (53–100) | 71.4 (56–86) | 83.3 (53–100) |
ILD, interstitial lung disease; PARo52A, positive anti-Ro52 antibodies.
ILD | PARo52A | (CI 95%) | |||
---|---|---|---|---|---|
Ss, % | Sp, % | PPV, % | NPV, % | ||
n = 26 | n = 35 | 96.2 (89–100) | 83.3 (53–100) | 71.4 (56–86) | 83.3 (53–100) |
ILD, interstitial lung disease; PARo52A, positive anti-Ro52 antibodies.